Comprehensive prediction of drug-protein interactions and side effects for the human proteome

Zhou, Hongyi, Gao, Mu, Skolnick, Jeffrey·2015·Scientific Reports
DOI 10.1038/srep11090

Cited by (143)

Items 101–143 of 143

  1. Characterization of rutin bindingto HRAS and MAPK3 and its clinical prognostic relevancein lung cancer: Using in silico and clinical prognostic experimental design
    Hossam Mohammed Kamli · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  2. Topological alternate centrality measure capturing drug targets in the network of MAPK pathways
    V.K. Md Aksam, V.M. Chandrasekaran, Sundaramurthy Pandurangan · 2018 · IET Systems Biology
  3. Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes
    Despoina P. Kiouri, Charalampos Ntallis, Konstantinos Kelaidonis, M. Peana, S. Tsiodras, T. Mavromoustakos, A. Giuliani, H. Ridgway, G. Moore, J. Matsoukas et al. · 2023 · Proteomes
  4. Investigating key genes and biological pathways for therapeutic drug compound identification and survival analysis of chronic lymphocytic leukemia and hepatitis B associated hepatocellular carcinoma using system biology approach
    Md. Anayt Rabbi, Md. Manowarul Islam, Arnisha Akhter, Md. Ashraf Uddin · 2024 · Network Modeling Analysis in Health Informatics and Bioinformatics
  5. System Theoretic Methods in Drug Discovery and Vaccine Formulation: Review and Perspectives
    Ankita Sharma, Yen-Che Hsiao, Abhishek Dutta · 2025 · Drugs and Drug Candidates
  6. 3D structural prediction with docking for five stages of lymphoma
    B J Bipin Nair, Athulya Viswan, Veerubhotla Sri Pranav · 2017 · IEEE International Conference for Convergence in Technology (I2CT)
  7. A scientist engineer’s contribution to therapeutic discovery and development
    Jennifer L. Wilson · 2018 · Experimental Biology and Medicine
  8. Negative controls of chemical probes can be misleading
    Jinyoung Lee, Matthieu Schapira · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Computational analysis for infectious diseases surveillance and host-pathogen interactions (in the context of Influenza A viruses)
    Biruhalem Taye · 2017
  11. Identifying Novel Targets by using Drug-binding Site Signature: A Case Study of Kinase Inhibitors
    Hammad Naveed, Corinna Reglin, Thomas E. O. Schubert, Xin Gao, Stefan T. Arold, Michael L. Maitland · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  12. PolypharmDB, a Deep Learning-Based Resource, Quickly Identifies Repurposed Drug Candidates for COVID-19
    Dar’ya S. Redka, Stephen Scott MacKinnon, Melissa R. Landon, Andreas Windemuth, Naheed Kurji, Vijay M. Shahani · 2020 · ChemRxiv
  13. Faculty Opinions recommendation of Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects.
    M Madan Babu, Maria Marti · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  14. Faculty Opinions recommendation of Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects.
    Jason A. Flannick · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  15. Machine Learning Prediction of Drug Side Effects in Clinical Trials
    Diego Galeano, Alberto Paccanaro · 2022 · SSRN Electronic Journal
  16. Identifying repurposed drugs with moderate anti-influenza virus activity through computational prioritization of drug-target pairs
    Biruhalem Taye, Roland Thünauer, Richard Joseph Sugrue, Sebastian Maurer‐Stroh, Jan Kosiński · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Artificial intelligence-based parametrization of Michaelis–Menten maximal velocity: Toward in silico New Approach Methodologies (NAMs)
    Achilleas Karakoltzidis, Spyros Karakitsios, Dimosthenis Andreas Sarigiannis · 2024 · Research Square
  18. Recent Mass Spectrometry Technologies in Pharmacoproteomics
    Bright D. Danquah, Charles A. Okai, Kwabena F.M. Opuni · 2024 · Springer eBooks
  19. Additional file 2 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  20. Additional file 15 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  21. Additional file 1 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  22. Additional file 6 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  23. Additional file 5 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  24. Additional file 4 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  25. Additional file 17 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  26. Additional file 16 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  27. Additional file 3 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  28. Additional file 7 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  29. Additional file 19 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  30. Additional file 12 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  31. Additional file 13 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  32. Additional file 20 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  33. Additional file 14 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  34. Additional file 10 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  35. Additional file 11 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  36. Additional file 21 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  37. Additional file 18 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  38. Additional file 8 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  39. Additional file 9 of Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes
    Jennifer L. Fisher, Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne · 2024 · Figshare
  40. Machine learning approaches to quantify nanoscale variations in the mechanical properties of soft nanoparticles
    Benjamin Baylis, John Dutcher · 2026 · Soft Matter
  41. Machine learning approaches for drug virtual screening
    Benoît Playe · 2019
  42. Solvants et sites de liaison hydrophobes
    Caroline Senac · 2018 · theses.fr (ABES)
  43. Target-biology and interactome-derived signatures predict target-level associations with safety-related drug attrition
    Jordan Breffle, Alex Jones, Susan Dina Ghiassian · 2026 · Scientific Reports